Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ledrogon Apr 02, 2019 5:17pm

97 Views

Post# 29572641

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NR. RESVERLOGIX ANNOUNCES $15.1 in Private Placement

Nope...no late day rally, although RVXCF did close up. If you check google currency converter $3.39 CDN = $2.54 USD, exactly where both closed, so now they're in lock step....sometimes they're a little out of synch.

Just for fun I did a chart comparison of RVXCF and RVX.TO on yahoo finance's charting tool....interestingly there is some wide variances at times. YTD it shows RVXCF up 9% while RVX.TO is only up 3%. Go back 6 months and its RVX.TO that's up 7.3% while RVXCF is only up 1.6%. But go back 1 full year and they're pretty much even, with both up about 92%.

Bullboard Posts

Bitcoin company adds convenience of modern banking